News, Scientific publications and Events

The combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.

Octavian Alexea, Vlad Bacarea and Nuria Pique.

Treatment with oligo- and polysaccharides and reticulated protein is safe, improving IBS symptoms and quality of life of patients with diarrhoea-predominant IBS.

Uro-gynecology Scientific Publication UTIPRO® PLUS / UTIPRO® PLUS AF

Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiology. Published online: 27 Feb 2017

Guglietta A.

Future Microbiology journal has published an article by Dr Antonio Guglietta entitled Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. This article reviews the role of non-pharmacological alternatives which act as mechanical protective barriers on the intestinal mucosa, preventing the adhesion of uropathogenic bacteria and their subsequent proliferation and migration in the urinary tract.

Gastroenterology Scientific Publication XILAPLUS® / XILAPLUS® AF

Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial.

Lucio Gnessi, Vladimir Bacarea, Marius Marusteri and Núria Piqué.

At 6 h xyloglucan produced a statistically significant higher decrease in the mean number of type 6 and 7 stools compared with diosmectite and S. boulardii.

xilaplus at 6h xyloglucan produced a statistically

You are here

Magazine

The combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.

Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiology. Published online: 27 Feb 2017

Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial.

Let's meet in..

Magazine

The combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.

Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiology. Published online: 27 Feb 2017

Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial.

Pages

Let's meet in..